Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
31
1
2
3
4
5
6
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
31
1
2
3
Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO [...]
Allergan to Present at the 37th Annual J.P. Morgan Healthcare Conference
2019-01-07    
3:30 pm
Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, [...]
Johnson & Johnson to Participate in 37th Annual JP Morgan Health Care Conference
2019-01-07    
3:30 pm
Johnson & Johnson (NYSE: JNJ) will participate in the 37th Annual JP Morgan Health Care Conference on Monday, Jan. 7th, at the Westin St. Francis in San Francisco.  Joseph J. [...]
Halozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2019-01-09    
10:30 am
Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference in San [...]
International Conference on Chemistry, Chemical Engineering and Chemical Process
2019-01-30 - 2019-01-31    
All Day
It is a great pleasure and an honor to extend to you a warm invitation to attend the "International Conference on Chemistry, Chemical Engineering and [...]
Streamline HCP Workflow • Drive Patient Education • Navigate the Specialty Prescribing Landscape
2019-02-01    
12:00 am
The original and most comprehensive conference series dedicated entirely to strategies for effective utilization of e-Rx and EHR technologies is back for 2019. Whether new [...]
Latest News

No compelling evidence for health benefits of non-sugar sweeteners

Alzheimer's Drug
Old man visits doctor in hospital for consultation on health and treatment
The weight of evidence hints at benefits, but the full picture has yet to emerge

There is no compelling evidence to indicate important health benefits of non-sugar sweeteners, and potential harms cannot be ruled out, suggests a review of published studies in The BMJ today.

Growing concerns about health and quality of life have encouraged many people to adopt healthier lifestyles and avoid foods rich in sugars, salt, or fat. Foods and drinks containing non-sugar sweeteners rather than regular (“free”) sugars have therefore become increasingly popular.

Although several non-sugar sweeteners are approved for use, less is known about their potential benefits and harms within acceptable daily intakes beacuse the evidence is often limited and conflicting.

To better understand these potential benefits and harms, a team of European researchers analysed 56 studies comparing no intake or lower intake of non-sugar sweeteners with higher intake in healthy adults and children.

Measures included weight, blood sugar (glycaemic) control, oral health, cancer, cardiovascular disease, kidney disease, mood and behaviour. Studies were assessed for bias and certainty of evidence.

Overall, the results show that, for most outcomes, there seemed to be no statistically or clinically relevant differences between those exposed to non-sugar sweeteners and those not exposed, or between different doses of non-sugar sweeteners.

For example, in adults, findings from a few small studies suggested small improvements in body mass index and fasting blood glucose levels with non-sugar sweeteners, but the certainty of this evidence was low.

Lower intakes of non-sugar sweeteners were associated with slightly less weight gain (-0.09 kg) than higher intakes, but again the certainty of this evidence was low.

In children, a smaller increase in body mass index score was seen with non-sugar sweeteners compared with sugar, but intake of non-sugar sweeteners made no differences to body weight.

And no good evidence of any effect of non-sugar sweeteners was found for overweight or obese adults or children actively trying to lose weight.

The researchers point out that this is the most comprehensive review on this topic to date, and will inform a World Health Organization guideline for health experts and policy makers.

However, they stress that the quality of evidence in many of the studies was low, so confidence in the results is limited. And they say longer term studies are needed to clarify whether non-sugar sweeteners are a safe and effective alternative to sugar.

In a linked editorial, Vasanti Malik at Harvard T.H. Chan School of Public Health agrees that more studies are needed to understand the potential health effects of non-sugar sweeteners and to guide policy development.

Based on existing evidence, she says use of non-sugar sweeteners as a replacement for free sugars, particularly in sugar sweetened drinks, “could be a helpful strategy to reduce cardiometabolic risk [chances of having diabetes, heart disease or stroke] among heavy consumers, with the ultimate goal of switching to water or other healthy drinks.”

“Policies and recommendations will need updating regularly, as more evidence emerges to ensure that the best available data is used to inform the important public health debate on sugar and its alternatives,” she concludes.

Source